BE788516A
(fr)
|
1971-09-10 |
1973-03-07 |
Lonza Ag |
Procede de fabrication d'esters alcoxyacetylacetiques
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
DE2658401A1
(de)
|
1976-12-23 |
1978-07-06 |
Merck Patent Gmbh |
Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
US4575694A
(en)
|
1984-03-05 |
1986-03-11 |
Allied Corporation |
Coaxial connector
|
DE3900736A1
(de)
|
1989-01-12 |
1990-07-26 |
Hoechst Ag |
Positiv arbeitendes strahlungsempfindliches gemisch enthaltend einen mehrfunktionellen (alpha)-diazo-(beta)-ketoester, verfahren zu dessen herstellung und strahlungsempfindliches aufzeichnungsmaterial enthaltend dieses gemisch
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
US6703396B1
(en)
|
1990-02-01 |
2004-03-09 |
Emory University |
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
|
US5914331A
(en)
|
1990-02-01 |
1999-06-22 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
DE4014649A1
(de)
|
1990-05-08 |
1991-11-14 |
Hoechst Ag |
Neue mehrfunktionelle verbindungen mit (alpha)-diazo-ss-ketoester- und sulfonsaeureester-einheiten, verfahren zu ihrer herstellung und deren verwendung
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
SE9702772D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
AU1403099A
(en)
|
1997-11-14 |
1999-06-07 |
Merck & Co., Inc. |
Alpha-1a adrenergic receptor antagonists
|
JP2002529455A
(ja)
|
1998-11-09 |
2002-09-10 |
ジェームズ・ブラック・ファウンデーション・リミテッド |
ガストリンおよびコレシストキニン受容体リガンド類
|
GB2345058A
(en)
|
1998-12-01 |
2000-06-28 |
Cerebrus Pharm Ltd |
Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system
|
HUP0201472A3
(en)
|
1998-12-25 |
2006-03-28 |
Shionogi & Co |
Aromatic heterocycle compounds having hiv integrase inhibiting activities
|
US20040039060A1
(en)
|
2000-06-14 |
2004-02-26 |
Ryuichi Kiyama |
Inhibitor for enzyme having two divalent metal ions as active centers
|
CN101513402B
(zh)
|
2001-08-10 |
2012-03-21 |
盐野义制药株式会社 |
抗病毒药
|
NZ532018A
(en)
|
2001-10-03 |
2004-12-24 |
Ucb S |
Pyrrolidinone derivatives
|
ES2258668T3
(es)
|
2001-10-26 |
2006-09-01 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Hidroxipirimidina carboxamidas n-sustituidas inhibidoras de hiv integrasa.
|
US7176217B2
(en)
|
2001-11-13 |
2007-02-13 |
Shiseido Co., Ltd. |
Azabicyclo compound matrix metalloprotease inhibitor and skin preparation
|
WO2004004657A2
(en)
|
2002-07-09 |
2004-01-15 |
Bristol-Myers Squibb Company |
Hiv integrase inhibitors
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
ATE443048T1
(de)
|
2002-11-20 |
2009-10-15 |
Japan Tobacco Inc |
4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
|
NZ540728A
(en)
|
2003-01-14 |
2008-08-29 |
Gilead Sciences Inc |
Compositions and methods for combination antiviral therapy
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
JP2007519735A
(ja)
|
2004-01-30 |
2007-07-19 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害剤として有用であるn−ベンジル−3,4−ジヒドロキシピリジン−2−カルボキサミド及びn−ベンジル−2,3−ジヒドロキシピリジン−4−カルボキサミド化合物
|
AU2005220767A1
(en)
|
2004-03-09 |
2005-09-22 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
WO2006028523A2
(en)
|
2004-04-29 |
2006-03-16 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
WO2005110415A1
(en)
|
2004-05-07 |
2005-11-24 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
US7273859B2
(en)
|
2004-05-12 |
2007-09-25 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors: cyclic pyrimidinone compounds
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
US7531554B2
(en)
|
2004-05-20 |
2009-05-12 |
Japan Tobacco Inc. |
4-oxoquinoline compound and use thereof as HIV integrase inhibitor
|
EP2332538A1
(en)
|
2004-05-21 |
2011-06-15 |
Japan Tobacco, Inc. |
Combinations comprising a 4-isoquinolone derivative and anti-HIV agents
|
WO2006030807A1
(ja)
|
2004-09-15 |
2006-03-23 |
Shionogi & Co., Ltd. |
Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体
|
CA2634499A1
(en)
|
2004-12-23 |
2006-06-29 |
Virochem Pharma Inc. |
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
EP1852434B1
(en)
|
2005-02-21 |
2011-07-13 |
Shionogi Co., Ltd. |
Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
|
ES2667868T5
(es)
|
2005-04-28 |
2023-06-01 |
Viiv Healthcare Co |
Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora de la integrasa del VIH
|
AR057023A1
(es)
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
|
CA2616314A1
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
ES2569357T3
(es)
|
2005-10-27 |
2016-05-10 |
Shionogi & Co., Ltd. |
Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora sobre integrasa de HIV
|
JP4676536B2
(ja)
|
2005-12-30 |
2011-04-27 |
ギリアド サイエンシズ, インコーポレイテッド |
Hivインテグラーゼ阻害剤の薬物動態の改善方法
|
US7601844B2
(en)
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
EP2452682A1
(en)
|
2006-02-01 |
2012-05-16 |
Japan Tobacco, Inc. |
Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
|
US8420821B2
(en)
|
2006-03-06 |
2013-04-16 |
Japan Tobacco Inc. |
Process for production of 4-oxoquinoline compound
|
US8383819B2
(en)
|
2006-03-06 |
2013-02-26 |
Japan Tobacco Inc. |
Method for producing 4-oxoquinoline compound
|
US7893055B2
(en)
|
2006-06-28 |
2011-02-22 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
JP2009543865A
(ja)
|
2006-07-19 |
2009-12-10 |
ユニバーシティ オブ ジョージア リサーチ ファウンデーション, インコーポレーテッド |
ピリジノンジケト酸:併用療法におけるhiv複製の阻害剤
|
KR101433621B1
(ko)
|
2006-09-07 |
2014-08-27 |
알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 |
누클레오시드 포스포릴라아제 및 히드롤라아제의 비고리형 아민 억제제
|
ES2536923T3
(es)
|
2006-09-12 |
2015-05-29 |
Gilead Sciences, Inc. |
Proceso e intermedios para preparar inhibidores de la integrasa del VIH
|
EP2084160A1
(en)
|
2006-10-18 |
2009-08-05 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
LT3150586T
(lt)
|
2007-02-23 |
2020-03-10 |
Gilead Sciences, Inc. |
Terapinių agentų farmakokinetinių savybių moduliatoriai
|
US20080280945A1
(en)
|
2007-05-09 |
2008-11-13 |
Sachin Lohani |
Crystalline forms of an HIV integrase inhibitor
|
SG182229A1
(en)
|
2007-06-29 |
2012-07-30 |
Gilead Sciences Inc |
Therapeutic compositions and the use thereof
|
JP5547067B2
(ja)
|
2007-06-29 |
2014-07-09 |
ギリアード サイエンシーズ, インコーポレイテッド |
治療組成物およびその使用
|
US20090258939A1
(en)
|
2007-07-31 |
2009-10-15 |
Wendye Robbins |
Pyrone analog compositions and methods
|
AR068403A1
(es)
|
2007-09-11 |
2009-11-18 |
Gilead Sciences Inc |
Proceso e intermediarios para la preparacion de inhibidores de integrasa
|
CN101918365B
(zh)
|
2007-11-16 |
2013-10-09 |
吉联亚科学股份有限公司 |
人类免疫缺陷病毒复制的抑制剂
|
GB0803019D0
(en)
|
2008-02-19 |
2008-03-26 |
Btg Int Ltd |
Fluorinated compounds
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
WO2010011813A1
(en)
|
2008-07-23 |
2010-01-28 |
Alkermes, Inc. |
Complex of trospium and pharmaceutical compositions thereof
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP2330902B1
(en)
|
2008-07-25 |
2012-11-14 |
GlaxoSmithKline LLC |
Chemical compounds
|
PT2320908E
(pt)
|
2008-07-25 |
2014-03-06 |
Shionogi & Co |
Pró-fármacos de dolutegravir
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP2320909B8
(en)
|
2008-07-25 |
2016-03-30 |
VIIV Healthcare Company |
Chemical compounds
|
BRPI0923217A2
(pt)
|
2008-12-11 |
2017-05-23 |
Glaxosmithkline Llc |
processos para a preparação de um composto de piridona, e para a preparação de uma forma cristalina, composto, sal ou um hidrato deste, forma cristalina de um sal de sódio ou um hidrato deste, e, composição farmacêutica.
|
ES2763540T3
(es)
|
2008-12-11 |
2020-05-29 |
Viiv Healthcare Co |
Intermedios para inhibidores de la integrasa del VIH de carbamoilpiridona
|
WO2010110231A1
(ja)
|
2009-03-26 |
2010-09-30 |
塩野義製薬株式会社 |
置換された3-ヒドロキシ-4-ピリドン誘導体
|
TWI518084B
(zh)
|
2009-03-26 |
2016-01-21 |
鹽野義製藥股份有限公司 |
哌喃酮與吡啶酮衍生物之製造方法
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
TWI520959B
(zh)
|
2009-06-15 |
2016-02-11 |
鹽野義製藥股份有限公司 |
經取代的多環胺甲醯吡啶酮衍生物及其用途
|
WO2011028044A2
(ko)
|
2009-09-02 |
2011-03-10 |
이화여자대학교 산학협력단 |
피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
|
EA202190473A3
(ru)
|
2010-01-27 |
2021-12-31 |
Вайв Хелткер Компани |
Противовирусная терапия
|
NZ601847A
(en)
|
2010-02-26 |
2014-03-28 |
Japan Tobacco Inc |
1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
|
TWI582097B
(zh)
|
2010-03-23 |
2017-05-11 |
Viiv醫療保健公司 |
製備胺甲醯吡啶酮衍生物及中間體之方法
|
WO2011139637A1
(en)
|
2010-05-03 |
2011-11-10 |
Philadelphia Health & Education Corporation |
Small-molecule modulators of hiv-1 capsid stability and methods thereof
|
WO2012003498A1
(en)
|
2010-07-02 |
2012-01-05 |
Gilead Sciences, Inc. |
2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
|
ES2634490T3
(es)
|
2010-07-02 |
2017-09-28 |
Gilead Sciences, Inc. |
Derivados de ácido napht-2-ylacetico para tratar el sida
|
WO2012009009A2
(en)
|
2010-07-14 |
2012-01-19 |
Addex Pharma S.A. |
Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
ES2710609T3
(es)
|
2010-08-05 |
2019-04-26 |
Shionogi & Co |
Procedimiento de preparación de un compuesto que tiene actividad inhibidora de la integrasa del HIV
|
AU2011307087B2
(en)
|
2010-09-24 |
2016-11-10 |
Shionogi & Co., Ltd. |
Substituted polycyclic carbamoyl pyridone derivative prodrug
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
PE20141066A1
(es)
|
2011-04-21 |
2014-09-05 |
Gilead Sciences Inc |
Compuestos de benzotiazol
|
WO2012151361A1
(en)
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
WO2012151567A1
(en)
|
2011-05-05 |
2012-11-08 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for preventing and treating influenza
|
JP6205354B2
(ja)
|
2011-07-06 |
2017-09-27 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivの処置のための化合物
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
PL2742051T3
(pl)
|
2011-09-14 |
2017-06-30 |
Mapi Pharma Limited |
Amorficzna postać soli sodowej dolutegrawiru
|
BR112014008896A2
(pt)
|
2011-10-12 |
2017-04-18 |
Shionogi & Co |
derivado de piridona policíclico tendo atividade inibidora de integrase
|
WO2013087581A1
(en)
|
2011-12-12 |
2013-06-20 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
ES2571479T3
(es)
|
2012-04-20 |
2016-05-25 |
Gilead Sciences Inc |
Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
US20150166520A1
(en)
|
2012-07-20 |
2015-06-18 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyrimidinone derivatives useful for the treatment of hiv infection
|
EP2877469A4
(en)
|
2012-07-25 |
2016-04-06 |
Merck Sharp & Dohme |
SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS INHIBITORS OF HIV INTEGRASE
|
EA026089B1
(ru)
|
2012-08-03 |
2017-02-28 |
Джилид Сайэнс, Инк. |
Способ и промежуточные соединения для получения ингибиторов интегразы
|
CA2890983A1
(en)
|
2012-11-08 |
2014-05-15 |
Bristol-Myers Squibb Company |
Heteroaryl substituted pyridyl compounds useful as kinase modulators
|
CN104902905A
(zh)
|
2012-12-14 |
2015-09-09 |
葛兰素史克有限责任公司 |
药物组合物
|
WO2014099586A1
(en)
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
SI2822954T1
(sl)
|
2012-12-21 |
2016-07-29 |
Gilead Sciences, Inc. |
Policiklične karbamoilpiridonske spojine in njihova farmacevtska uporaba
|
US20140221355A1
(en)
|
2012-12-21 |
2014-08-07 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
US20160000721A1
(en)
|
2012-12-21 |
2016-01-07 |
Merck Sharp & Dohme Corp. |
Gastro-retentive formulations
|
SG11201504982PA
(en)
|
2012-12-27 |
2015-07-30 |
Japan Tobacco Inc |
SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
|
US9951079B2
(en)
|
2013-06-13 |
2018-04-24 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
|
EP3252058B1
(en)
*
|
2013-07-12 |
2021-01-20 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
|
NO2865735T3
(sl)
*
|
2013-07-12 |
2018-07-21 |
|
|
WO2015039348A1
(en)
*
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
EP3049081B1
(en)
|
2013-09-27 |
2019-11-27 |
Merck Sharp & Dohme Corp. |
Substituted quinolizine derivatives useful as hiv integrase inhibitors
|
US20150146340A1
(en)
|
2013-11-26 |
2015-05-28 |
Qualcomm Incorporated |
Multilayer ceramic capacitor including at least one slot
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
WO2015110897A2
(en)
|
2014-01-21 |
2015-07-30 |
Laurus Labs Private Limited |
Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
|